725TiP Osimertinib combined with bevacizumab and chemotherapy as first-line treatment in EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations
Yan-Juan Xiong, Yu Wang, Wenxiong Zhang, Minjie Shen et autres
cn (code pays fourni par la source)